Abstract
To explore the effects of oral omeprazole on preoperative gastric fluid pH and volume in children, 104 healthy in-patients aged 4–9 yr were randomly allocated to four groups (n = 26). Subjects in the Omeprazole-Omeprazole Group received two doses of omeprazole (20 mg per dose), those in the Placebo-Placebo Group, two doses of placebo, those in the Placebo-Omeprazole and Omeprazole-Placebo Groups, one dose each of the two preparations by mouth. For each treatment regimen, the first medication was administered at 9:00 p.m. on the night before surgery and the second at 5:30 a.m. on the morning of the day of surgery (three hours preoperatively). Children undergoing elective surgery were offered 10 nil · kg−1 of apple juice three hours before induction of anaesthesia. After induction of anaesthesia and tracheal intubation, gastric fluid was aspirated through a large-bore, multiorifice orogastric tube and analyzed for pH and total fluid volume. The administration of omeprazole at bedtime before surgery increased gastric pH (3.3 ± 1.3 vs 2.0 ± 0.6, P < 0.05) in comparison with placebo, as did two doses of omeprazole (pH = 4.8 ± 1.6, P < 0.05). A single dose of omeprazole administration on the morning of the day of surgery failed to increase gastric pH. There was a reduction in the number of children with a pH < 2.5 and a volume > 0.4 ml · kg−1 in the Omeprazole-Omeprazole and Omeprazole-Placebo Groups compared with the Placebo-Placebo or Placebo-Omeprazole Groups. Oral omeprazole 20 mg administered on the night prior to surgery will improve the gastric environment at the time of induction of anaesthesia, thus reducing the potential risk of pneumonitis, should the aspiration of gastric contents occur following the induction of anaesthesia. These data also suggest that this drug, when administered in a single dose of approximately 1.0 mg · kg−1 three hours before surgery, is ineffective in increasing gastric fluid pH to > 2.4.
Résumé
Cette étude évalue à la période préopératoire les effets de l’oméprazole oral sur le liquide et le volume gastriques des enfants. Cent quatre patients hospitalisés âgés de quatre à neuf ans sont répartis au hasard en quatre groupes (n = 26). Le groupe oméprazole-oméprazole reçoit deux doses d’oméprazole (20 mg par dose), le groupe placebo, deux doses de placebo, les groupes placebo-oméprazole et oméprazole-placebo, chacun une dose des deux préparations orales. La première médication est toujours administrée à 9.00 p.m. la veille de la chirurgie et la seconde à 5.30 a.m. le matin de la chirurgie (trois heures avant l’intervention). Les enfants programmés pour une chirurgie élective peuvent boire 10 ml · kg−1 de jus de pomme trois heures avant l’anesthésie. Après l’induction de l’anesthésie, le liquide gastrique est aspiré par une sonde orale de gros calibre à plusieurs orifices et analysé pour son pH et son volume total. L’oméprazole administré au coucher augmente le pH (3,3 ± 1,3 vs 2,0 ± 0,6, P < 0,05) comparativement au placebo, ainsi que les deux doses d’oméprazole (pH = 4,8 ± 1,6, P < 0,05). Une dose unique d’oméprazole administrée le matin de la chirurgie n’augmente pas le pH gastrique. On note une réduction du nombre d’enfants à pH < 2,5 et à volume > 0,4 ml · kg−1 dans les groupes oméprazole-oméprazole et oméprazole-placebo comparativement aux groupes placebo-placebo et oméprazoleplacebo. L’administration d’oméprazole 20 mg le soir qui précède la chirurgie améliore les conditions gastriques à l’induction de l’anesthésie pour ainsi diminuer le risque de pneumonite d’aspiration. Ces données suggèrent aussi que l’oméprazole administré en dose unique de 1,0 mg · kg−1 trois heures avant la chirurgie n’augmente pas le p H gastrique à un niveau > 2,4.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Wallmark B, Jaresten B-M, Larsson H, Ryberg B, Brandstrom A, Fellenius E. Differentiation among inhibitory ac tions of omeprazole, cimetidine, and SCN− on gastric acid secretion. Am J Physiol 1983; 245: G64-G71.
Regårdh C-G, Gabrielsson M, Hoffman KJ, Löfberg I, Skånberg I. Pharmacokinetics and metabolism of omepra zole in animals and man — an overview. Scand J Gastroen terol 1985; 20: 79–94.
Clissold SP, Campoli-Richards DM. Omeprazole: a pre liminary review of its pharmacodynamic and pharmacoki netic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs 1986; 32: 15–47.
Protzer U, Holtermiiller KH. Omeprazoe. Pharmakologie und therapeutische Wirksamkeit. Dtsch Med Wochenschr 1993; 118: 230–9.
Biemond I, Klinkenberg-Knol EC, Lamers CBHW, Meuwissen SGM. Serum pepsinogens after interruption of long-term maintenance therapy with omeprazole in patients with reflux esophagitis. Dig Dis Sci 1993; 38: 932–6.
Nelis GF, Westerveld BD. Treatment of resistant reflux oesophagitis in children with omeprazole. European Journal of Gastroenterology and Hepatology 1990; 2: 215–7.
De Giacomo C, Fiocca R, Villiani L, Licardi G, Scotta MS, Solcia E. Omeprazole treatment of severe peptic dis ease associated with antral G cell hyperfunction and hyper pepsinogenemia I in an infant. J Pediatr 1990; 117: 989–93.
Cruickshank RH, Morrison DA, Bamber PA, Nimmo WS. Effect of i.v. omeprazole on the pH and volume of gastric contents before surgery. Br J Anaesth 1989; 63: 536–40.
Gin T, Ewart MC, Yau G, Oh TE. Effect of oral omepra zole on intragastric pH and volume in women undergoing elective Caesarean section. Br J Anaesth 1990; 65: 616–9.
Ewart MC, Yau G, Gin T, Kotur CF, Oh TE. A compari son of the effects of omeprazole and ranitidine on gastric secretion in women undergoing elective Caesarean section. Anaesthesia 1990; 45: 527–30.
Hendolin H, Suojaranta- Ylinen R, Alhava E. Effect of single-dose omeprazole and ranitidine on gastric juice acid ity and volume in patients undergoing laparotomy. Acta Anaesthesiol Scand 1993; 37: 484–7.
Inoue M, Shirakawa T, Kajiyama G, et al. Clinical study of a proton pump inhibitor, omeprazole (1). The effect on gastric acid secretion by continuous intragastric pH moni toring. Basic Pharmacol Ther 1988; 16: 493–503.
Olbe L, Lind T, Cederberg C, Ekenved G. Effect of omep razole on gastric acid secretion in man. Scand J Gastroen terol Suppl 1986; 21: 105–7.
Brunton LL. Agents for control of gastric acidity and treatment of peptic ulcers.In: Gilman AG, Rail TW, Nies AS, Taylor P (Eds.). Goodman and Gilman’s The Pharma cological Basis of Therapeutics (8th ed.). New York: Per gamon Press, 1990; 897–913.
Helander HF, Ramsay C-H, Regardh C-G. Localization of omeprazole and metabolites in the mouse. Scand J Gas troenterol Suppl 1985; 20: 95–104.
Goudsouzian N, Cote CJ, Liu LMP, Dedrick DF. The dose-response effects of oral cimetidine on gastric pH and volume in children. Anesthesiology 1981; 55: 533–6.
Goudsouzian NG, Young ET The efficacy of ranitidine in children. Acta Anaesthesiol Scand 1987; 31: 387–90.
Jahr JS, Burckart G, Smith SS, Shapiro J, Cook DR. Effects of famotidine on gastric pH and residual volume in pediatric surgery. Acta Anaesthesiol Scand 1991; 35: 457–60.
Tryba M, Yildiz F, Kiihn K, Dziuba M, Zenz M. Rectal and oral cimetidine for prophylaxis of aspiration pneumoni tis in paediatric anaesthesia. Acta Anaesthesiol Scand 1983; 27: 328–30.
Christensen S, Farrow-Gillespie A, Lerman J. Effects of ranitidine and metoclopramide on gastric fluid pH and vol ume in children. Br J Anaesth 1990; 65: 456–60.
Guay J, Santerre L, Gaudreault P, Goulet B, Dupuis C. Effects of oral cimetidine and ranitidine on gastric pH and residual’volume in children. Anesthesiology 1989; 71: 547–9.
Kemmotsu O, Mizushima M, Morimoto Y, et al. Effect of preanesthetic intramuscular ranitidine on gastric acidity and volume in children. J Clin Anesth 1991; 3: 451–5.
Yoshinari M, Minamida Y. New drug information from DI. Pharma Medica 1991; 9: 165–76.
Fujisawa Pharmaceutical Industries. Data on file: outline of Omepral®. Fujisawa Pharmaceutical Industries, Osaka, Japan.
Olsson GL, Hallen B, Hambraeus-Jonzon K. Aspiration during anaesthesia: a computer-aided study of 185,358 an aesthetics. Acta Anaesthesiol Scand 1986; 30: 84–92.
Tiret L, Nivoche Y, Hatton F, Demonts JM, Vourc’h G. Complications related to anaesthesia in infants and chil dren. Br J Anaesth 1988; 61: 263–9.
Tiret L, Demonts JM, Hatton F, Vourc’h G. Complica tions associated with anaesthesia — a prospective survey in France. Can Anaesth Soc J 1986; 33: 336–44.
Weaver MK. Perioperative pulmonary aspiration in chil dren: a review. Paediatric Anaesthesia 1993; 3: 333–8.
Bricker SRW, McLuckie A, Nightingale DA. Gastric aspi rates after trauma in children. Anaesthesia 1989; 44: 721–4.
Naesdal J, Lind T, Bergsaker-Aspoy J, et al. The rate of healing of duodenal ulcers during omeprazole treatment. Scand J Gastroenterol 1985; 20: 691–5.
Karjoo M, Kane RE. Omeprazole treatment in children with peptic esophagitis refractory to ranitidine. Gastroen terol 1992; 102: A93.
Rowbotham DF. Omeprazole — a useful new agent? (Editorial). Br J Anaesth 1990; 65: 607–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nishina, K., Mikawa, K., Maekawa, N. et al. Omeprazole reduces preoperative gastric fluid acidity and volume in children. Can J Anaesth 41, 925–929 (1994). https://doi.org/10.1007/BF03010936
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03010936